- Neo/adjuvant immunotherapy in the treatment of non-small cell lung cancer2022 | Faculty of Medicine in Pilsen
- Neo-/adjuvant immunotherapy and targeted therapy of non-small cell lung cancer2023 | Faculty of Medicine in Pilsen
- Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study2022 | First Faculty of Medicine
- Advances in management of stage III non-small cell lung cancer2022 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CA209-238Publication without faculty affiliation
- Immunotherapy in the adjuvant treatment of patients with malignant melanoma2021 | Faculty of Medicine in Hradec Králové
- Adjuvant durvalumab after successful concomitant chemoradiotherapy of non-small cell lung cancer treatment2021 | Faculty of Medicine in Pilsen
- Position of adjuvant therapy in the therapy of melanoma2018 | First Faculty of Medicine
- Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method2008 | First Faculty of Medicine, Third Faculty of Medicine
- Advances in Clinical Treatment of Malignant Melanoma: B-RAF Kinase Inhibition2011 | Third Faculty of Medicine